NHS England agrees funding for life-saving hepatitis C drug

BY IN Medication NO COMMENTS YET ,

NHS England has approved an £18.7 million investment in a new drug for the treatment of hepatitis C. Around 500 patients with acute liver failure, and/or awaiting liver transplantation, are expected to benefit from the decision to fund Sofosbuvir. The hepatitis C virus causes inflammation of the liver, affecting its ability to function. Whilst many

CONTINUE READING …

Access to Hepatitis C Drugs: Write Your MP

BY IN Medication NO COMMENTS YET ,

In this blog at Channel 4 News, Victoria Macdonald reports on continuing delays in access to hepatitis C treatments and concerns that NHS England is seeking to influence NICE decisions about new hepatitis C treatments on the basis on affordability, rather than cost-effectiveness: Officials at NHS England have been accused of interfering in a process to

CONTINUE READING …